Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2005
11/09/2005CN1694732A Method, compounds and preparations for the identification of sentinel lymph nodes
11/09/2005CN1694727A Injections for eye tissue containing drug bound to polyethylene glycol
11/09/2005CN1694721A Nucleic acid coated particles
11/09/2005CN1694709A Antibacterial medicinal composition of enhanced oral absorptivity
11/09/2005CN1694699A Percutaneous absorption preparations containing 3-methyl-phenyl-2-pyrazolin-5-one
11/09/2005CN1694689A Sustained release pharmaceutical formulation for inhalation
11/09/2005CN1694688A Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
11/09/2005CN1694687A Capsule and film-forming composition comprising gum arabic
11/09/2005CN1694686A Modified release oral dosage form
11/09/2005CN1694685A Transmucosal pharmaceutical administration form
11/09/2005CN1694660A Prosthetic foot with tunable performance
11/09/2005CN1692940A External-applied ointment used for treating thyropathy, and its prepn. method
11/09/2005CN1692900A Single-chamber, double-layered osmosis pump control-release system with holes on two sides
11/09/2005CN1226332C Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug
11/09/2005CN1226318C Medical copolymerized hydrogel and preparation method thereof
11/09/2005CN1226047C Pharmaceutical compositions
11/09/2005CN1226043C Oral tablet for treating psoriasis and its preparation method
11/09/2005CN1226037C Use of sucralfate for the treatment of cervical erosion
11/09/2005CN1226033C Method for preparing traditional Chinese medicine concentrated pill
11/08/2005US6962944 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
11/08/2005US6962931 Oral bioavailability of a CETP inhibitor
11/08/2005US6962908 Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
11/08/2005US6962905 Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
11/08/2005US6962747 comprised of stacks of lipid bilayers formed in a columnar structure, where the assembly process is mediated and regulated by chemical recognition events; useful as structural elements nanotechnology, drug delivery etc
11/08/2005US6962717 Pharmaceutical compositions
11/08/2005US6962716 Compositions and methods for biodegradable microspheres as carriers of bioactive substances
11/08/2005US6962715 Method and dosage form for dispensing a bioactive substance
11/08/2005US6962711 Cosmetic and dermatological preparations comprising increased electrolyte concentrations
11/08/2005US6962691 Topical spray compositions
11/08/2005US6962580 Vascular access port with needle detector
11/08/2005US6962006 Methods and apparatus for making particles using spray dryer and in-line jet mill
11/08/2005CA2382599C Flushable disposable polymeric products
11/08/2005CA2330390C Sugar coated tablets
11/08/2005CA2269501C Pellets having a core coated with an antifungal and a polymer
11/08/2005CA2229283C Prednisolone metasulphobenzoate preparation for the treatment of inflammatory bowel disease
11/08/2005CA2193405C Eyewash intended in particular for the treatment of the dry eye syndrome
11/08/2005CA2172055C Process (ii) for the preparation of powdered medicament
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/08/2005CA2149753C Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
11/08/2005CA2125685C Powders for inhalation and process for preparing them
11/07/2005CA2506492A1 Irrigation solution for use in ultrasound energy assisted surgery
11/03/2005WO2005103382A1 Treated crimped multi-ply product
11/03/2005WO2005103184A1 Adhesive for dermal patch and production process thereof
11/03/2005WO2005103157A1 Silicone vesicles
11/03/2005WO2005103106A1 Method of producing polymeric particles with selected size, shape, morphology and composition
11/03/2005WO2005103065A1 Anthracycline derivatives
11/03/2005WO2005103017A1 Method for increasing specific surface area of slightly soluble drug
11/03/2005WO2005102393A1 Patch for external use with elevated content of absorption promoter in pressure-sensitive adhesive base
11/03/2005WO2005102369A1 Pharmaceutical preparation containing bacterial cell wall skeleton component
11/03/2005WO2005102364A1 Compressed pharmaceutical compositions comprising peg and electrolytes
11/03/2005WO2005102359A1 Liposomal formulations of anthracycline agents and cytidine analogs
11/03/2005WO2005102354A1 Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
11/03/2005WO2005102351A1 Composition comprising a diuretic and/or cardiac glycoside for the treatment of dna viral infections of the eye
11/03/2005WO2005102334A2 Apparatus and method for transdermal delivery of fentany-based agents
11/03/2005WO2005102307A2 Beneficial effects of increasing local blood flow
11/03/2005WO2005102306A1 Anti-inflammatory analgesic adhesive patch
11/03/2005WO2005102295A1 Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
11/03/2005WO2005102294A2 Transdermal system secured against misuse
11/03/2005WO2005102293A1 Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar
11/03/2005WO2005102292A1 Chitosan embedded or encapsulated capsule
11/03/2005WO2005102291A1 Seamless capsule containing water-soluble active ingredient
11/03/2005WO2005102290A1 Pharmaceutical compositions of a biguanide and a sulfonylurea
11/03/2005WO2005102289A1 Clarithromycin extended release formulation
11/03/2005WO2005102288A2 Lozenge for delivery of dextromethorphan
11/03/2005WO2005102287A2 Pharmaceutical compositions for acute glucocorticoid therapy
11/03/2005WO2005102286A1 Method for the production of an abuse-proof, solid form of administration
11/03/2005WO2005102285A1 Tissue enhancement implant and method
11/03/2005WO2005102284A1 Protein-containing lipid implant for sustained delivery and its preparation method
11/03/2005WO2005102283A1 Dry powder pharmaceutical composition, its preparation process and stable aqueous suspension obtained from such composition
11/03/2005WO2005102282A1 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
11/03/2005WO2005102281A2 Porous calcium phosphate networks for synthetic bone material
11/03/2005WO2005102280A1 Magnetically targetable mitomycin c compositions and methods of their use
11/03/2005WO2005102279A2 Controlled gap techniques for fiber optics devices
11/03/2005WO2005102278A1 Method for preparation of poly-iclc and uses thereof
11/03/2005WO2005102277A1 A composition of a jetable microemulsion, a method of manufacturing thereof as well as a system of dispensing
11/03/2005WO2005102276A1 Antimicrobial compositions
11/03/2005WO2005102275A2 Galantamine salts, method of producing it and nasal composition thereof
11/03/2005WO2005102274A2 Method of stabilizing disordered cefovecin sodium salt
11/03/2005WO2005102273A2 Pharmaceutical compositions of a biguanide and a sulfonylurea
11/03/2005WO2005102272A2 Sustained-release dosage forms for cabergoline
11/03/2005WO2005102271A2 Pharmaceutical compositions for glucocorticoid replacement therapy
11/03/2005WO2005102270A2 Agent-releasing system comprising an agent-containing patch and at least one means regulating the release of agents
11/03/2005WO2005102269A2 An amine drug-containing slow-release granule preparation based on particles with a coating layer and the corresponding method of production
11/03/2005WO2005102268A2 Cholinesterase inhibitors in liposomes and their production and use
11/03/2005WO2005102248A2 Silicone vesicles containing actives
11/03/2005WO2005101983A2 Gastric retention system
11/03/2005WO2005084645A8 Embolic particles
11/03/2005WO2005084307A9 Use of lipid conjugates in the treatment of disease
11/03/2005WO2005071067A3 Non-animal origin stabilizers and processes for producing the same
11/03/2005WO2005070464A3 A tablet formulation of clopidogrel bisulphate
11/03/2005WO2005067887A3 Formulations of ramipril
11/03/2005WO2005065655A3 Method for producing keto-l-gulonic acid spray granules
11/03/2005WO2005063777A8 Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
11/03/2005WO2005062761A3 Stabilized prednisolone sodium phosphate solutions
11/03/2005WO2005053608A8 Preparing for individualized dosage forms of medicaments
11/03/2005WO2005041942A3 Three-dimensional mammalian ovarian follicular cell and ovarian follicle culture systems in a biocompatible matrix
11/03/2005WO2005034915A3 Screening method for evaluation of bilayer-drug interaction in liposomal compositions
11/03/2005WO2005020954A3 Proton pump inhibitor formulations, and methods of preparing and using such formulations
11/03/2005WO2005018605A3 Novel formulation of ropinirole
11/03/2005WO2004064811A8 A composition material for transmucosal delivery
1 ... 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 ... 2991